Interview: Robin Turner, General Manager, Roche Portugal
Robin Turner, General Manager of Roche Portugal, looks back on the evolution of the affiliate, and describes how the company managed to recover its debt owed by Portuguese hospitals through…
Roche focuses on developing medicines and diagnostics that will help patients live longer, better lives. Roche strives to address unmet medical needs through excellence in science—from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
http://www.roche.com/index.htm
Estrada Nacional 249-1
2720
AMADORA
Tel: 351 – 21 425 70 00
Fax: 351 – 21 418 66 77
Robin Turner, General Manager of Roche Portugal, looks back on the evolution of the affiliate, and describes how the company managed to recover its debt owed by Portuguese hospitals through…
Portuguese pharmaceutical group Bluepharma consists of ten companies that represent different parts of the medicine value chain. The success of Bluepharma during Portugal’s crisis was due to a strong focus…
Almirall Portugal stopped all commercial activity in 2011 to focus only on the market access of new, innovative products being introduced through the organization’s active R&D pipeline. Country Manager Rui…
José Carlos Machado, Vice President & Researcher at The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) speaks about Portugal’s excellent research capacity and the need…
José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies today, as well as the need for a revamp of…
Jose Pereira Leal, Group Leader Head of the Bioinformatics Unit at Instituto Gulbenkian de Ciencia, discusses the institute’s unique selling point, stating that, “researchers will continue to come and stay…
João Lobo Antunes, Founder of Institute of Molecular Medicine (IMM), Portugal gives his insights into Portugal’s strengths in science and technology, as well as his ambitions to grow IMM into…
Agustín Oleaga, Managing Director of DHL Supply Chain Portugal discusses the challenges of supply chain management as it relates to the life sciences industry in Portugal, and how the country’s…
António Donato, Vice President of Tecnimede Group, Portugal, discusses the Portuguese company’s internationalization and expansion process while highlighting the ways in which the Portuguese pharmaceutical environment must change in order…
Abel Vizeu Fernandes, Country Director at Kedrion Portugal discusses how national tenders for plasma-derived products opened the company up to more opportunities for growth in Portugal, as well as his…
Between Portugal’s two main distribution channels of hospitals and pharmacies, hospitals have suffered in particular. As the pharmaceutical industry’s largest customer, it has been critical for government to work with…
Luis Almeida, CEO of Luzitin Portugal, talks about the Innovation of the Decade award Luzitin received for its patented technology, what exactly is so unique and innovative about this technology,…
Rui Carrington, CEO of OCP Portugual, a Pharmaceutical distributor which has undergone a significant evolution over the years as part of an adaptation to the changing market trends in Portugal,…
See our Cookie Privacy Policy Here
